Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.8K Sell
622
-25
-4% -$2.03K ﹤0.01% 513
2025
Q4
$42K Hold
647
﹤0.01% 376
2025
Q3
$96.4K Sell
647
-8
-1% -$1.17K 0.01% 218
2025
Q2
$95.1K Sell
655
-14
-2% -$2.02K 0.01% 211
2025
Q1
$84.6K Sell
669
-7
-1% -$885 0.01% 224
2024
Q4
$70.3K Hold
676
0.01% 244
2024
Q3
$57.7K Hold
676
0.01% 281
2024
Q2
$47.7K Sell
676
-8
-1% -$534 0.01% 278
2024
Q1
$43.1K Hold
684
0.01% 297
2023
Q4
$40.6K Sell
684
-6
-0.9% -$328 0.01% 287
2023
Q3
$31.1K Buy
+690
New +$28.1K 0.01% 338

Other funds holding LRN

McIlrath & Eck's LRN Position: Q1 2026 in Review

McIlrath & Eck reduced its Stride (LRN) stake by 3.9% in Q1 2026, selling an estimated $2.03K and leaving 622 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #513.

McIlrath & Eck first reported a position in LRN in Q3 2023 and has held it in 11 quarters since. The position peaked at $96.4K in Q3 2025. 421 funds tracked by Wall St. Rank hold LRN as of Q1 2026.

  • McIlrath & Eck held 622 shares of Stride worth $54.8K as of Q1 2026.
  • McIlrath & Eck sold 25 Stride shares in Q1 2026, an estimated $2.03K.
  • Stride made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #513 holding.
  • McIlrath & Eck first reported a position in Stride in Q3 2023 and has held it in 11 quarters since.
  • McIlrath & Eck's Stride position peaked at $96.4K in Q3 2025.
  • 421 funds tracked by Wall St. Rank held Stride as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.